ATRO Medical is a spin-off company from Radboudumc and DSM Biomedical and develops the Trammpolin® meniscus prosthesis. Meniscus damage and wear are important causes of osteoarthritis of the knee. The Trammpolin®
device intends to replace the damaged meniscus with an implantable prosthesis, with the aim of restoring the protective function of the meniscus by acting as a joint spacer. The company is addressing a large unmet medical need, as an increasing number of patients with knee injuries undergo meniscectomy (partial or total removal of the meniscus). These patients gradually develop osteoarthritis, resulting in pain and reduced mobility. Current treatment options for these patients are limited and have poor outcomes. Trammpolin® aims to provide a cost-effective solution to reduce pain and restore mobility.
Dr. Hunik graduated in environmental engineering at the University of Wageningen. There, he also obtained his PhD on bioprocess technology. After which he started working at Unilever for four years as project manager biotechnology. Next, he worked at DSM where he fulfilled several roles as marketing manager B2B and new business development manager. From 2010-2016, he worked as director of strategy at DSM. In 2016, he co-founded ATRO Medical, and he acts as CEO ever since. He is responsible for the project management, attracting investors, team building and the financial management.
Dr. van Tienen graduated as a medical doctor from the Radboudumc in 1998. He obtained his PhD in 2004 at the Radboudumc on ‘in vivo engineering of knee joint meniscus’. He has over 10 years’ experience as orthopaedic knee surgeon and over 20 years’ experience in meniscus research. He published over 30 publications on the meniscus and meniscus prostheses. He has an active research line at the Radboudumc on the development of meniscus prostheses. In 2016 he co-founded ATRO Medical, and acts as CMO ever since. He is responsible for the medical research, partnerships with medical institutions and the development of the surgical procedure.
Mr. Pikaart obtained his bachelor’s degree in Mechanical Engineering and his master’s degree in Biomedical Engineering at the Eindhoven University of Technology, in respectively 2004 and 2008. After graduating, he moved into the medical device industry where he fulfilled multiple clinical and regulatory positions at Medpace Medical Device B.V. for 10 years in which he build in-depth experience in project and operational management, clinical research, and regulatory affairs. In November 2017, he started as Clinical Research Director at Atro Medical, where he is responsible for the clinical strategy, regulatory submissions for marketing authorizations in the EU and the US, and the design, management and execution of the clinical study programs.
Mr. van Minnen obtained his Bachelor and Master’s degree in Biomedical Engineering from the University of Twente, in respectively 2012 and 2015. His Master Thesis entitled: Predicting gait using a patient-specific musculoskeletal model of patients with hip dysplasia. From 2015 to 2017 he worked as a research scientist in the Orthopaedic Research Lab of the Radboudumc, as part of the BMM2 Trammpolin project. In April 2017, he started working at ATRO Medical where he is currently involved in the design and preclinical testing of the Trammpolin® meniscus prosthesis, as well as the company’s quality management.
Mrs. Brinks has a medical background as certified clinical perfusionist. She worked as clinical perfusionist at Erasmus MC and Radboudumc, where she also did research on anticoagulation during cardiac surgery. She studied Management Sciences and has over 15 years’ experience in the medical device industry in various management and board positions covering disciplines like sales, manufacturing, business development, among others at Medtronic and Indes.
In December 2017, she started as Operations Manager at ATRO Medical, where she is responsible for selection and contracting of suppliers, outsourcing of production, purchasing, production planning and quality of the delivered products.